Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Self-portrait of a woman with cancer and her children, for article on triple-negative breast cancer vaccine

Triple-negative breast cancer vaccine shows good response in first clinical trial of patients

By / / Good News For Humankind

A new breast cancer vaccine sparked an immune response in three out of four patients during its first human safety trial — with no serious side effects reported. The Cleveland Clinic study targeted triple-negative breast cancer, an aggressive subtype that resists most standard treatments and disproportionately affects younger women and Black women. The vaccine works by training the immune system to recognize a lactation protein found in most TNBC tumors but absent in healthy adult tissue, giving immune cells a clear target. Next come larger trials testing whether it can prevent recurrence and even attack active tumors. It’s an early but hopeful signal in the growing field of cancer immunotherapy, where teaching the body to find cancer itself is reshaping what treatment can look like.

Waving a pride flag

Thailand to legalize same-sex marriage

By / / Good news links

The Southeast Asian country will become the third Asian nation, after Taiwan and Nepal, to legalize same-sex marriage. A new amendment to its Civil and Commercial Code will change the words “men and women” and “husband and wife” to “individuals” and “marriage partners.” The next step will be an amendment to the country’s pension fund law to recognize same-sex couples.

Sahara scimitar Oryx, for article on scimitar horned oryx

North Africa’s scimitar horned oryx becomes first species ever to be downlisted from extinct in the wild to endangered

By / / Good News For Humankind

The scimitar horned oryx just made conservation history as the first species ever downlisted from Extinct in the Wild to Endangered by the IUCN. This pale, curve-horned antelope vanished from the Sahara before the millennium, hunted to zero in the wild. Now a self-sustaining herd roams Chad’s Ouadi Rimé–Ouadi Achim Reserve, a protected area roughly the size of Scotland, rebuilt from zoo populations through nearly four decades of patient international collaboration. Even better, the oryx grazes grasslands open and helps slow the Sahara’s spread, making its return a quiet act of climate repair. For the 94 other species still surviving only in human care, it’s proof that “extinct” need not be the final word.

Furnace flames

Massachusetts becomes first U.S. state to approve phase-out of natural gas as a source for residential heating

By / / Good news links

According to Inside Climate News, Massachusetts is the first state to take such a clear step to phase out natural gas, but it likely won’t be the last. At least 11 other states, including California, Colorado, Illinois, Maryland, Minnesota, Nevada, New Jersey, New York, Oregon, Rhode Island and Washington — as well as Washington, D.C. — have ongoing regulatory cases that are exploring the future of natural gas.

ITER Fusion Reactor. Tokamak. Thermonuclear Experimental power plant. Industrial zone with power station atomic energy production. 3D Render, for article on fusion reactor Japan

Japan completes and begins operating world’s largest fusion reactor

By / / Good News For Humankind

Fusion energy just took a real step forward in Japan: JT-60SA, the largest experimental fusion reactor on Earth, has officially powered up in Ibaraki Prefecture. Standing six stories tall, it heats plasma to roughly 200 million degrees Celsius — hotter than the sun’s core — to study the same process that lights the stars. More than 500 scientists and 70 companies across Japan and the European Union built it together, and its job is to pave the way for ITER, the even larger reactor rising in France. Fusion still has a long road ahead, but moments like this remind us what becomes possible when nations pool decades of expertise toward a shared, emissions-free future.

Pills spilling out of pill bottle, for article on march-in rights policy

U.S. sets policy to seize patents of government-funded drugs if price deemed too high

By / / Good News For Humankind

Drug patent seizures are back on the table for the first time in over 40 years, with the Biden administration releasing a draft roadmap that explicitly lets the federal government license out medicines to competitors when companies charge prices most Americans can’t afford. The power has existed since 1980 but was never used or even defined — until now. Price itself is now a factor: if a drug was built on taxpayer-funded research through agencies like the NIH, and the company sells it out of reach of ordinary patients, generics could be authorized. Even as a credible threat, this reframes who publicly funded science is really for — and could shift drug pricing fights well beyond U.S. borders.